Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common stock, par value $0.001 per share (the "Common Stock")
-
Shares outstanding
-
138,764,349
-
Total 13F shares
-
20,597,873
-
Share change
-
+18,349,409
-
Total reported value
-
$109,582,112
-
Put/Call ratio
-
218%
-
Price per share
-
$5.32
-
Number of holders
-
84
-
Value change
-
+$97,619,255
-
Number of buys
-
75
-
Number of sells
-
2
Institutional Holders of ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") (ARWR) as of Q2 2016
As of 30 Jun 2016,
ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") (ARWR) was held by
84 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,597,873 shares.
The largest 10 holders included
OppenheimerFunds, Inc., VANGUARD GROUP INC, BlackRock Fund Advisors, QVT Financial LP, BlackRock Institutional Trust Company, N.A., JPMORGAN CHASE & CO, BAKER BROS. ADVISORS LP, STATE STREET CORP, AMERIPRISE FINANCIAL INC, and NORTHERN TRUST CORP.
This page lists
84
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.